Trials / Completed
CompletedNCT06526546
ADVENT Trial Long Term Outcomes Evaluating Atrial Fibrillation Progression Study
ADVENT Trial Long Term Outcomes Evaluating Atrial Fibrillation Progression (ADVENT LTO Study)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 364 (actual)
- Sponsor
- Boston Scientific Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The (ADVENT LTO) is an observational, non-significant risk study to assess the progression of atrial fibrillation in subjects who received ablation treatment with either the FARAPULSE Pulsed Field Ablation System or thermal ablation in the ADVENT Trial.
Detailed description
This study is an observational, non-significant risk study. Subjects who participated in the FARAPULSE ADVENT Trial (NCT04612244) will be approached for participation.
Conditions
Timeline
- Start date
- 2024-10-31
- Primary completion
- 2025-12-08
- Completion
- 2025-12-08
- First posted
- 2024-07-30
- Last updated
- 2026-03-02
Locations
25 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT06526546. Inclusion in this directory is not an endorsement.